- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
DIPNA PHARMACHEM has filed its Annual Secretarial Compliance Report for the year ended March 31, 2026. The report highlights significant non-compliance issues, including the company's failure to appoint a qualified Company Secretary, delayed submission of investor complaint statements, and late financial results. These lapses led to total fines of approximately Rs. 7.07 Lakh levied by BSE. Management has indicated they are in the process of appointing a Company Secretary and will ensure timely future compliance. This update reveals persistent corporate governance challenges for the company.